Diffuse alveolar hemorrhage

Southern Medical Journal

Volumn 104, Issue 4, 2011, Pages 269-274

  Newsome, Brandi R ^a   Morales, Juan E ^a  

^a UNIVERSITY OF SOUTH CAROLINA   (United States)

Author keywords

diffuse alveolar hemorrhage; goodpastures syndrome; plasmapharesis; Wegener granulomatosis

Indexed keywords

ABCIXIMAB; AMINOCAPROIC ACID; AZATHIOPRINE; CLOPIDOGREL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; EPTIFIBATIDE; METHYLPREDNISOLONE; PENICILLAMINE; PREDNISONE; RECOMBINANT BLOOD CLOTTING FACTOR 7A; TRANEXAMIC ACID;

BONE MARROW TRANSPLANTATION; CAUSAL ATTRIBUTION; CLINICAL EVALUATION; CLINICAL FEATURE; DOSE RESPONSE; DRUG MEGADOSE; GOODPASTURE SYNDROME; HEART INFARCTION; HISTOPATHOLOGY; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; LABORATORY TEST; LUNG HEMORRHAGE; LUNG HEMOSIDEROSIS; MITRAL VALVE REPLACEMENT; MITRAL VALVE STENOSIS; OXYGENATION; PLASMAPHERESIS; REVIEW; SYSTEMIC LUPUS ERYTHEMATOSUS; THORAX RADIOGRAPHY; WEGENER GRANULOMATOSIS;

HEMORRHAGE; HUMANS; LUNG DISEASES; PULMONARY ALVEOLI; RISK FACTORS;

EID: 79955017827     PISSN: 00384348     EISSN: None     Source Type: Journal    
DOI: 10.1097/SMJ.0b013e3182126d3b     Document Type: Review

References (45)

1. Collard HR, Schwarz MI. Diffuse alveolar hemorrhage. Clin Chest Med 2004;25:583-592, vii. (Pubitemid 39149804)
2. Travis WD, Colby TV, Lombard C, et al. A clinicopathologic study of 34 cases of diffuse pulmonary hemorrhage with lung biopsy confirmation. Am JSurg Pathol 1990;14:1112-1125.
3. Zamora MR, Warner ML, Tuder R, et al. Diffuse alveolar hemorrhage and systemic lupus erythematosus. Clinical presentation, histology, survival, and outcome. Medicine (Baltimore) 1997;76:192-202. (Pubitemid 27255822)
4. Greening AP, Hughes JM. Serial estimations of carbon monoxide dif-fusing capacity in intrapulmonary haemorrhage. Clin Sci (Lond) 1981; 60:507-512. (Pubitemid 11002230)
5. Mark EJ, Ramirez JF. Pulmonary capillaritis and hemorrhage in patients with systemic vasculitis. Arch Pathol Lab Med 1985;109:413-418. (Pubitemid 15052654)
6. Fontenot AP, Schwarz A, Marvin I. Diffuse alveolar hemorrhage. In: Schwarz MI, Talmadge E, eds. Interstitial Lung Disease. Hamilton, ON, Canada: BC Decker; 2003:632-656.
7. Hasleton PS. Adult respiratory distress syndrome. In: Hasleton PS, ed. Spencer's Pathology ofthe Lung. New York: McGraw-Hill; 1996:375-400.
8. Heslet L, Nielsen JD, Levi M, et al. Successful pulmonary administra-tion of activated recombinant factor VII in diffuse alveolar hemorrhage. Crit Care 2006;10:R177.
9. Estella A, Jareno A, Perez-Bello Fontaina L. Intrapulmonary adminis-tration of recombinant activated factor VII in diffuse alveolar haemor-rhage: areport oftwo case stories. Cases J2008;1:150.
10. Sindet-Pedersen S, Ramstrom G, Bernvil S, et al. Hemostatic effect of tranexamic acid mouthwash in anticoagulant-treated patients undergoing oral surgery N Engl J Med 1989;320:840-843. (Pubitemid 19094704)
11. Taghaddomi RJ, Mirzaee A, Attar AS, et al. Tranexamic acid reduces blood loss in off-pump coronary artery bypass surgery. J Cardiothorac Vasc Anesth 2009;23:312-315.
12. Solomonov A, Fruchter O, Zuckerman T, et al. Pulmonary hemorrhage: a novel mode oftherapy. Respir Med 2009;103:1196-1200.
13. Sanders M, Spies CD, Martiny V, et al. Mortality associated with ad-ministration of highdose tranexamic acid and aprotinin in primary open-heart procedures: a retrospective analysis. Crit Care 2010;14:R148.
14. Cordier JF, Valeyre D, Guillevin L, et al. Pulmonary Wegener's granu-lomatosis. A clinical and imaging study of 77 cases. Chest 1990;97: 906-912. (Pubitemid 20132316)
15. Klemmer PJ, Chalermskulrat W, Reif MS, et al. Plasmapheresis therapy for diffuse alveolar hemorrhage in patients with small-vessel vasculitis. Am J Kidney Dis 2003;42:1149\1153.
16. Nguyen T, Martin MK, Indrikovs AJ. Plasmapheresis for diffuse alveolar hemorrhage in a patient with Wegener's granulomatosis: case report and review ofthe literature. J Clin Apher 2005;20:230-234.
17. Matthay RA, Schwarz MI, Petty TL, et al. Pulmonary manifestations of systemic lupus erythematosus: review of twelve cases of acute lupus pneumonitis. Medicine (Baltimore) 1975;54:397\409.
18. Teague CA, Doak PB, Simpson IJ, et al. Goodpasture's syndrome: an analysis of 29 cases. Kidney Int 1978;13:492-504. (Pubitemid 8373075)
19. Fouret PJ, Touboul JL, Mayaud CM, et al. Pulmonary Kaposi's sarcoma in patients with acquired immune deficiency syndrome: a clinicopatholog-ical study. Thorax 1987;42:262-268. (Pubitemid 17058939)
20. Vincent B, Flahault A, Antoine M, et al. AIDS-related alveolar hem-orrhage: a prospective study of 273 BAL procedures. Chest 2001;120: 1078-1084. (Pubitemid 32960075)
21. Afessa B, Tefferi A, Litzow MR, et al. Outcome of diffuse alveolar hemorrhage in hematopoietic stem cell transplant recipients. Am J Respir Crit Care Med 2002;166:1364-1368. (Pubitemid 35292703)
22. Majhail NS, Parks K, Defor TE, et al. Diffuse alveolar hemorrhage and infection-associated alveolar hemorrhage following hematopoietic stem cell transplantation: related and high-risk clinical syndromes. Biol Blood Marrow Transplant 2006;12:1038-1046. (Pubitemid 44597153)
23. Lewis ID, DeFor T, Weisdorf DJ. Increasing incidence of diffuse alve-olar hemorrhage following allogeneic bone marrow transplantation: cryptic etiology and uncertain therapy Bone Marrow Transplant 2000; 26:539-543.
24. Wanko SO, Broadwater G, Folz RJ, et al. Diffuse alveolar hemorrhage: retrospective review ofclinical outcome in allogeneic transplant recipients treated with aminocaproic acid. Biol Blood Marrow Transplant 2006;12: 949-953.
25. Milman N, Pedersen FM. Idiopathic pulmonary haemosiderosis. Epide-miology, pathogenic aspects and diagnosis. Respir Med 1998;92:902-907. (Pubitemid 28401215)
26. Byrd RB, Trunk G Systemic lupus erythematosus presenting as pulmo-nary hemosiderosis. Chest 1973;64:128-129.
27. Leaker B, Cambridge G, du Bois RM, et al. Idiopathic pulmonary haemo-siderosis: a form of microscopic polyarteritis? Thorax 1992;47:988-990.
28. Kuhn C. Systemic lupus erythematosus in a patient with ultrastructural lesions of the pulmonary capillaries previously reported in the review as due to idiopathic pulmonary hemosiderosis. Am Rev Respir Dis 1972; 106:931-932.
29. Chryssanthopoulos C, Cassimos C, Panagiotidou C. Prognostic criteria in idiopathic pulmonary hemosiderosis in children. Eur J Pediatr 1983; 140:123-125. (Pubitemid 13096252)
30. Saeed MM, Woo MS, MacLaughlin EF, et al. Prognosis in pediatric idiopathic pulmonary hemosiderosis. Chest 1999;116:721-725. (Pubitemid 29428491)
31. Ioachimescu OC, Sieber S, Kotch A. Idiopathic pulmonary haemosid-erosis revisited. Eur Respir J2004;24:162-170.
32. Wroblewski BM, Stefanovic CR, McDonough VM, et al. The challenges of idiopathic pulmonary hemosiderosis and lung transplantation. Crit Care Nurse 1997;17:39\44.
33. Calabrese F, Giacometti C, Rea F, et al. Recurrence of idiopathic pul-monary hemosiderosis in a young adult patient after bilateral single-lung transplantation. Transplantation 2002;74:1643-1645. (Pubitemid 36014243)
34. Louie S, Gamble CN, Cross CE. Penicillamine associated pulmonary hemorrhage. JRheumatol 1986;13:963-966. (Pubitemid 17203938)
35. Vizioli LD, Cho S. Amiodarone-associated hemoptysis. Chest 1994;105: 305-306. (Pubitemid 24029129)
36. Iskander S, Raible DG, Brozena SC, et al. Acute alveolar hemorrhage and orthodeoxia induced by intravenous amiodarone. Catheter Cardiovasc Interv 1999;47:61-63.
37. Meyer MM, Meyer RJ. Nitrofurantoin-induced pulmonary hemorrhage in a renal transplant recipient receiving immunosuppressive therapy: case report and review ofthe literature. J Urol 1994;152:938-940. (Pubitemid 24245975)
38. Vincent F, Bensousan TA. Re: nitrofurantoin-induced pulmonary hem-orrhage in a renal transplant recipient receiving immunosuppressive therapy: case report and review ofthe literature. J Urol 1995;154:214.
39. Morales JE, Iltchev D, Allen JN, et al. Life-threatening diffuse alveolar hemorrhage related to crack cocaine use: spontaneous resolution without steroids. Chest 2003;124(suppl):243S.
40. Bailey ME, Fraire AE, Greenberg SD, et al. Pulmonary histopathology in cocaine abusers. Hum Pathol 1994;25:203-207. (Pubitemid 24079642)
41. Baldwin GC, Choi R, Roth MD, et al. Evidence of chronic damage to the pulmonary microcirculation in habitual users of alkaloidal ("crack") cocaine. Chest 2002;121:1231-1238. (Pubitemid 34280448)
42. Iskandar SB, Kasasbeh ES, Mechleb BK, et al. Alveolar hemorrhage: an underdiagnosed complication of treatment with glycoprotein IIb/IIIa inhibitors. J Interv Cardiol 2006;19:356-363. (Pubitemid 44185831)
43. Kalra S, Bell MR, Rihal CS. Alveolar hemorrhage as a complication of treatment with abciximab. Chest 2001;120:126-131. (Pubitemid 32744868)
44. Cannageiter SC, Rosendaal FR, Briet E. Thromboembolic and bleeding complications in patients with mechanical prosthetic heart valve pros-theses. Circulation 1994;89:635-641. (Pubitemid 24056190)
45. Ananthasubramaniam K, Beattie JN, Rosman HS, et al. How safely and for how long can warfarin therapy be withheld in prosthetic heart valve patients hospitalized with a major hemorrhage? Chest 2001;119:478-484. (Pubitemid 32163760)